India is the worst hit Country by the second wave of COVID. Millions of people are getting severely affected by the second wave. In the meanwhile, hospitals are reporting a rare fungal infection in COVID patients. This disease is known as “black fungal disease” or Mucormyscosis.
A doctor, eye specialist working in three different hospitals of Mumbai, India told the news channels that he dealt with more than 40 people who are infected with this fungal disease.
According to the doctor, the cases of Mucormycosis have rapidly increased in the second wave of COVID and he also added that he only treated about 10 patients with the same disease in previous 2 years.
This disease majorly affected the patients who were having diabetes and had COVID as well. The disease started to develop after 2 weeks of recovery from COVID.
Also the major symptoms of Mucormycosis are; swelling over one side of the face, headache, fever, nasal congestion, blackening of nose, chest pain and breathing difficulties. Look
This is a lethal disease and most of the patient had to undergo surgery and get their eyes removed to stop it from spreading further.
The doctors says the those who are critically ill and treated with steroids are in more risk of developing this fungal infection. The steroids have proven to be effective in reducing the lung infections and inflammation but they also have side effects. They suppress the immunity of the person which eventually leads to blowing up of secondary infections like these fungal ones.
Moreover he said, diabetes it self lowers the immunity which favors catching of COVID and in the course of treating COVID , it further boosts these fungal infections.
But luckily, there are no cases around the world except India and there is still no major outbreak for this disease yet.
The experts says that the major issue leading to this much trouble is the poorly maintained diabetes and the numbers are particularly high in India. Maintaining diabetes wold definitely help in overcoming these kind of secondary diseases after COVID.